4
Clinical Trials associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group) / Not yet recruitingPhase 3 A Multicenter, Randomized, Double-blind, Controlled Phase III Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) Therapy for Knee Osteoarthritis.
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy
A Multicenter, Randomized, Double-blind, Controlled Phase II Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) for the Treatment of Knee Osteoarthritis
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy
A Phase I, Randomized, Single-centered, Double-blinded Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis
Evaluate the safety and efficacy of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis.
100 Clinical Results associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
100 Translational Medicine associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
100 Patents (Medical) associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
100 Deals associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)